Announced Strategic Partnership with Grocery Logistics Leader IFCO to Digitize their Global RPC Pool Completed Transfer of Production from Singapore to State-of-the-art Thailand Facility Launched Partnership with Narravero to Accelerate Digital Product Passport Adoption and Compliance Identiv, Inc. (NASDAQ: INVE), a global leader in RFID- and BLE-enabled Internet of Things (IoT) solutions, today released its […]
Gen Raises its Annual Guidance on Better-Than-Expected Results Gen Digital Inc. (NASDAQ: GEN), a global leader dedicated to powering Digital Freedom, released its results for its first quarter fiscal year 2026, which ended July 4, 2025. https://mma.prnewswire.com/media/2745858/Gen_Q1FY26_Earnings.jpg “FY26 is off to a strong start, with Q1 results beating expectations,” said Vincent Pilette, CEO of Gen.
(NASDAQ:OMDA), Revenue of $61 million, up 49%52% Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Highlights Total Members of 752,000, up 52% compared
(NASDAQ:BACK), Project will leverage Ignite Proteomics' reverse-phase protein array (RPPA) platform to profile tumor-immune signaling in breast-cancer samples Golden, CO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (OTCQB: BACK), today announced a one-year research collaboration with Vanderbilt University Medical Center (VUMC) to characterize protein-signaling pathways that help
(NASDAQ:CDTX), Phase 2b NAVIGATE clinical trial evaluating CD388 for the prevention of seasonal influenza met primary and all secondary efficacy endpoints for all dose groups End of Phase 2 meeting request submitted to the U.S. Food and Drug Administration (FDA) Closed upsized public offering for gross proceeds of $402.5 million; significantly strengthened balance sheet to
Second Quarter 2025 Revenue was $513.6 Million Net Loss was $6.7 Million or negative 1.3 Percent of Revenue (Net Income of $10.6 Million or 2.1 Percent of Revenue Non-GAAP) Adjusted EBITDA was $51.8 Million or 10.1 Percent of Revenue Updates Revenue Outlook for Full Year 2025 TTEC Holdings, Inc. (NASDAQ:TTEC), a leading global CX (customer
(NASDAQ:JYNT), – Refranchised 37 clinics; Franchises now represent 92% of the portfolio – – Acquired rights to the Northwest regional developer territory – SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, posted operating highlights and limited financial information for the quarter
(Other OTC:IDXG),(OTC US:IDXG), â— Q2 Revenue of $9.2 million â— Q2 Cash Collections of $10.8 million â— Q2 Thyroid test volume up 16% year-over-year to record levels â— Q2 Thyroid revenue of $8.7M; up 25% year-over-year to record levels PARSIPPANY, NJ, Aug. 07, 2025 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX:
(NYSE:FLUT),(LSE:FLTR),(OTC US:FLUT),(Other OTC:FLUT), NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Flutter Entertainment (NYSE: FLUT; LSE: FLTR) (“Flutter”) the world's leading online sports betting and iGaming operator today announces Q2 results, and increased 2025 guidance. Key financial highlights: In $ millions except where stated otherwise Three months ended June 30, 2025 2024 YOY Average monthly
Aligned with FDA on del-brax accelerated and full approval pathways for FSHD, reported positive topline data from Phase 1/2 FORTITUDE™ trial, and initiated global confirmatory Phase 3 study Planned del-zota BLA submission at year end 2025 for DMD44 on track to be Avidity's first BLA submission On track for three potential BLA submissions over a